Marinus Pharmaceuticals, Inc. is committed to improving the lives of patients suffering from drug-resistant seizures and neuropsychiatric disorders through the development of a new and safe drug candidate, ganaxolone, which offers an alternative treatment option for acute and chronic illnesses. Ganaxolone is a drug candidate designed to exhibit antiepileptic, anxiolytic, antidepressant, and sedative activity by virtue of its G...
Marinus Pharmaceuticals, Inc. is committed to improving the lives of patients suffering from drug-resistant seizures and neuropsychiatric disorders through the development of a new and safe drug candidate, ganaxolone, which offers an alternative treatment option for acute and chronic illnesses. Ganaxolone is a drug candidate designed to exhibit antiepileptic, anxiolytic, antidepressant, and sedative activity by virtue of its GABAA receptor modulating properties.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.